Absorbable Hemostatic Agent Downclassification Endorsed By Panel
This article was originally published in The Gray Sheet
Executive Summary
Content review of FDA's planned special controls guidance was instrumental in the General & Plastic Surgery Devices Panel's July 24 recommendation that absorbable hemostatic agents be downclassified from Class III to Class II